|
1
|
Jin X and Mu P: Targeting breast cancer
metastasis. Breast Cancer (Auckl). 9 Suppl 1:S23–S34. 2015.
|
|
2
|
Kimbung S, Loman N and Hedenfalk I:
Clinical and molecular complexity of breast cancer metastases.
Semin Cancer Biol. 35:85–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bill R and Christofori G: The relevance of
EMT in breast cancer metastasis: Correlation or causality? FEBS
Lett. 589:1577–1587. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kodack DP, Askoxylakis V, Ferraro GB,
Fukumura D and Jain RK: Emerging strategies for treating brain
metastases from breast cancer. Cancer Cell. 27:163–175. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Milroy MJ: Breast cancer screening. S D
Med: Spec No. 69–73. 2015.
|
|
6
|
Xu M, Qian G, Xie F, Shi C, Yan L, Yu L,
Zheng T, Wei L and Yang J: Expression of epithelial cell adhesion
molecule associated with elevated ductular reactions in
hepatocellar carcinoma. Clin Res Hepatol Gastroenterol. 38:699–705.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Ma WY, Xu SC, Liang Y, Fu YB, Pang
B, Xin T, Fan HT, Zhang R, Luo JG, et al: The overexpression of
epithelial cell adhesion molecule (EpCAM) in glioma. J Neurooncol.
119:39–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goossens-Beumer IJ, Zeestraten EC, Benard
A, Christen T, Reimers MS, Keijzer R, Sier CF, Liefers GJ, Morreau
H, Putter H, et al: Clinical prognostic value of combined analysis
of Aldh1, Survivin, and EpCAM expression in colorectal cancer. Br J
Cancer. 110:2935–2944. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van der Gun BT, Melchers LJ, Ruiters MH,
de Leij LF, McLaughlin PM and Rots MG: EpCAM in carcinogenesis: The
good, the bad or the ugly. Carcinogenesis. 31:1913–1921. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao J, Yan Q, Wang J, Liu S and Yang X:
Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated
by AP1-dependent EpCAM expression in MCF-7 cells. J Cell Physiol.
230:775–782. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao J, Liu X, Yang F, Liu T, Yan Q and
Yang X: By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM
inhibits breast cancer cell growth and metastasis. Oncotarget.
6:27187–27198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shao Y, Sun K, Xu W, Li XL, Shen H and Sun
WH: Helicobacter pylori infection, gastrin and cyclooxygenase-2 in
gastric carcinogenesis. World J Gastroenterol. 20:12860–12873.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hoellen F, Kelling K, Dittmer C, Diedrich
K, Friedrich M and Thill M: Impact of cyclooxygenase-2 in breast
cancer. Anticancer Res. 31:4359–4367. 2011.PubMed/NCBI
|
|
14
|
Harris RE, Casto BC and Harris ZM:
Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J
Clin Oncol. 5:677–692. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thill M, Terjung A and Friedrich M: Breast
cancer-new aspects of tumor biology: Are calcitriol and
cyclooxygenase-2 possible targets for breast cancer? Eur J Gynaecol
Oncol. 35:341–358. 2014.PubMed/NCBI
|
|
16
|
Cheng J and Fan XM: Role of
cyclooxygenase-2 in gastric cancer development and progression.
World J Gastroenterol. 19:7361–7368. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Misra S and Sharma K: COX-2 signaling and
cancer: New players in old arena. Curr Drug Targets. 15:347–359.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thiel A, Mrena J and Ristimäki A:
Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev.
30:387–395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao J, Yan Q, Liu S and Yang X: Knockdown
of EpCAM enhances the chemosensitivity of breast cancer cells to
5-fluorouracil by downregulating the antiapoptotic factor Bcl-2.
PLoS One. 9:e1025902014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eberlein C, Rooney C, Ross SJ, Farren M,
Weir HM and Barry ST: E-Cadherin and EpCAM expression by NSCLC
tumour cells associate with normal fibroblast activation through a
pathway initiated by integrin alphavbeta6 and maintained through
TGFβ signalling. Oncogene. 34:704–716. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Philip R, Heiler S, Mu W, Büchler MW,
Zöller M and Thuma F: Claudin-7 promotes the epithelial-mesenchymal
transition in human colorectal cancer. Oncotarget. 6:2046–2063.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sankpal NV, Mayfield JD, Willman MW,
Fleming TP and Gillanders WE: Activator protein 1 (AP-1)
contributes to EpCAM-dependent breast cancer invasion. Breast
Cancer Res. 13:R1242011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan Q, Cheng JC, Qiu X, Chang HM and Leung
PC: EpCAM is up-regulated by EGF via ERK1/2 signaling and
suppresses human epithelial ovarian cancer cell migration. Biochem
Biophys Res Commun. 457:256–261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ni J, Cozzi P, Hao J, Beretov J, Chang L,
Duan W, Shigdar S, Delprado W, Graham P, Bucci J, et al: Epithelial
cell adhesion molecule (EpCAM) is associated with prostate cancer
metastasis and chemo/radioresistance via the PI3K/Akt/mTOR
signaling pathway. Int J Biochem Cell Biol. 45:2736–2748. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kroepil F, Dulian A, Vallböhmer D, Geddert
H, Krieg A, Vay C, Topp SA, Am Esch JS, Baldus SE, Gires O, et al:
High EpCAM expression is linked to proliferation and lauren
classification in gastric cancer. BMC Res Notes. 6:2532013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang D and Dubois RN: Eicosanoids and
cancer. Nat Rev Cancer. 10:181–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deshpande R, Mansara P and Kaul-Ghanekar
R: Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and
decreases the expression of HPV oncoproteins E6/E7 through
restoration of p53 and Rb expression in human cervical cancer cell
lines. Tumour Biol. 37:3295–3305. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kosaka T, Davydova J, Ono HA, Akiyama H,
Hirai S, Ohno S, Takeshita F, Aoki K, Ochiya T, Yamamoto M, et al:
Imaging and antitumoral effect of a Cyclo-oxygenase 2-specific
replicative adenovirus for small metastatic gastric cancer lesions.
Anticancer Res. 35:5201–5210. 2015.PubMed/NCBI
|
|
29
|
Yu S, Hou Q, Sun H, Liu J and Li J:
Upregulation of C-C chemokine receptor type 7 expression by
membrane-associated prostaglandin E synthase-1/prostaglandin E2
requires glycogen synthase kinase 3β-mediated signal transduction
in colon cancer cells. Mol Med Rep. 12:7169–7175. 2015.PubMed/NCBI
|
|
30
|
Perez AA, Balabram D, Rocha RM, da Silva
Souza Á and Gobbi H: Co-Expression of p16, Ki67 and COX-2 Is
associated with basal phenotype in high-grade ductal carcinoma in
situ of the breast. J Histochem Cytochem. 63:408–416. 2015.
View Article : Google Scholar : PubMed/NCBI
|
